All In MedTech

FDA Clearance Tracker · K182611

Qangio XA 3D

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: May 30, 2019 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

May 30, 2019

Substantially Equivalent

Time to decision

251 days

Received Sep 21, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K182611
Device name
Qangio XA 3D
Applicant location
Leiden, NL
Received
Sep 21, 2018
Decided
May 30, 2019
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 892.1600

Every decision under product code QHA

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QHA (X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Medis Medical Imaging Systems BV

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.